Bay Street News, February, 2024

All animal subjects tolerated maximum dosing Once-per-day human intranasal dosing regimen determined for clinical evaluation SARASOTA, FL, Feb. 28, 2024 […]

TORONTO, Feb. 28, 2024 (GLOBE NEWSWIRE) — Colliers International Group Inc. (TSX and NASDAQ: CIGI) (“Colliers” or the “Company”) is […]

LONDON, Feb. 28, 2024 (GLOBE NEWSWIRE) — Navigator Holdings Ltd. (described herein as “Navigator Gas” or the “Company”) (NYSE: NVGS), […]

JACKSONVILLE, Fla., Feb. 28, 2024 (GLOBE NEWSWIRE) — Regency Centers, L.P. (“Regency Centers”, the “Company” or “Regency”) announced today that […]

NEW YORK, Feb. 28, 2024 (GLOBE NEWSWIRE) — Stronghold Digital Mining, Inc. (NASDAQ: SDIG) (“Stronghold”, or the “Company”) will host […]

Financing includes significant participation from a number of large healthcare dedicated institutional and mutual fund investors Net proceeds, along with […]

WARSAW, Ind., Feb. 28, 2024 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively […]

CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying […]

Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional […]

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural […]